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Abstract
Introduction: Musculoskeletal ultrasound (US) represents a valid, reliable and sensitive-to-change tool for the evaluation 
of patients suffering from rheumatic conditions. This method demonstrates a wide applicability and availability, finding place 
in the clinical practice in rheumatology outpatient clinic. Aim: To perform an epidemiological evaluation related to the use 
of US in a university rheumatology outpatient clinic. Material and methods: During a 3-month period, data concerning con-
secutive patients attending to the US Unit of Department of Rheumatology, Sapienza University of Rome were registered. We 
collected the demographic data, the diagnosis, the reason for the US examination, the examined joints, as well as the requesting 
physicians’ specialty. Results: In the October-December 2013 period, 572 patients (M/F 137/435; mean age±SD 55.2±15.8 
years) were registered. The US examination was more frequently requested for the following diseases: rheumatoid arthritis 
(29.5%), osteoarthritis (10.6%), spondyloarthritis (9.1%), and connective tissue diseases (8.9%). In 239 of cases (41.8%), the 
US evaluation was requested for other indications. The US evaluation was requested slightly more frequently for monitoring 
(55.7%) compared to diagnosis (44.3%). The requesting physician was a rheumatologist in the majority of the cases (80.6%). 
The most frequent requested were the hand joints (28.9%) and wrists (23.3%). Conclusions: US examinations are most fre-
quently used in the evaluation of patients with rheumatoid arthritis and mainly to monitor the disease. The exam is requested 
mostly by rheumatologists. The hand joints and wrists were the most frequently evaluated.
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Introduction
An early and accurate diagnosis and careful manage-
ment of the patients affected by rheumatic diseases is a 
priority of the rheumatologist. Clinical examination can-
not differentiate between joint and peri-articular pathology, 
making difficult the achievement of precise diagnosis [1,2]. 
Moreover, the coexistence of both inflammatory and degen-
erative lesions could be another difficulty for the physician.
The application of musculoskeletal ultrasound (MS-
US) in rheumatology has rapidly evolved and this tech-
nique has been incorporated into routine clinical prac-
tice over the past decade. The diffusion of MS-US is 
largely the result of the technological development that 
has been allowed the production of high quality and 
easily interpretable images. The interest of the rheuma-
tologists was particularly focused on the inflammatory 
arthritis and the early identification of structural dam-
age [3-6].
Various rheumatic conditions require US examina-
tion both for the disease diagnosis and the monitor-
ing. Given this large variability of diseases assessed 
with US, an epidemiological analysis of the MS-US 
use in the clinical practice could be interesting. In the 
light of these premises, in the present study we aimed 
to perform an epidemiological description related to 
the use of US in a university rheumatology outpatient 
clinic.
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Material and methods 
We performed an epidemiological evaluation in a 
3-months period by including consecutive patients who 
attended Ultrasound Unit of Department of Rheumatol-
ogy, Sapienza University of Rome. The patients were re-
ferred to our Unit for different musculoskeletal manifes-
tations. Informed consent was obtained from all patients. 
We collected from all patients the following information: 
demographic data (age, sex), diagnosis, reason for per-
forming the US examination (diagnostic or monitoring), 
requesting physicians’ specialty, and joints examined. 
US examination of the requested areas was performed 
by the rheumatologists expert on MS-US from our de-
partment. The study was performed with a MyLab70 
XVG (Esaote, Italy) machine equipped with a multifre-
quency linear probe (4-13 MHz, 6-18MHz) in grey scale 
and power Doppler mode. US examination was carried 
out according to European League Against Rheuma-
tism (EULAR) guidelines for each anatomic region; the 
OMERACT definitions was applied to identify the US 
abnormalities [7,8]. All the identified findings were re-
corded in a standardized US report. 
Statistical analysis
We used version 13.0 of the SPSS statistical pack-
age. Normally distributed variables were summarized 
using the mean ± SD, and non-normally distributed 
variables by the median and range. The frequencies 
were summarized as percentage. Univariate compari-
sons between nominal variables were calculated using 
chi-square test or Fisher-test where appropriate. Two-
tailed P values were reported, P values less than 0.05 
were considered significant.
Results
We study a cohort of 572 patients (F/M 435/137; 
mean age±SD 55.2±15.8 years).  
Table I reports the frequency of the indications for the 
US examination that has been required mostly in patients 
affected by rheumatoid arthritis (RA) (169 cases, 29.5%). 
Within the connective tissue disease, 17 patients were 
affected by systemic lupus erythematosus (SLE), 16 by 
undifferentiated connective tissue disease, 15 by Sjogren’s 
syndrome (SS), and finally 3 by systemic sclerosis (SSc). 
Table I. Indications for the US examination
Indication N (%)
Rheumatoid Arthritis 169 (29.5)
Osteoarthritis 61 (10.6)
Spondyloarthritis 52 (9.1)
Connective Tissue Diseases 51 (8.9)
Psoriatic arthritis 36 (6.3)
Polymyalgia rheumatica 12 (2.1)
Fibromyalgia 11 (1.9)
Microcrystal arthropathies 6 (1.0)
Other conditions 174 (30.4)
Table II. Results on the joint examined with 
ultrasound.
Examined joint N (%)
Hand joints 403 (28.9)
Wrist 325 (23.3)
Knee 193 (13.8)






















RA 13 (2.9) 13 (2.9) 141 (32.1) 125 (28.5) 7 (1.6) 53 (12.1) 35 (7.9) 82 (18.6)
OA 8 (7.2) 1 (0.9) 37 (33.3) 22 (19,8) 8 (7.2) 23 (20.7) 2 (1.8) 10 (9.0)
AS 6 (4.3) 5 (3.6) 44 (31.8) 29 (21.0) 3 (2.2) 16 (11.6) 11 (7.9) 24 (17.4)
SLE 1 (2.9) – 12 (35.3) 8 (23.5) – 6 (17.6) – 7 (20.6)
SS 1 (3.2) – 12 (38.7) 11 (35.5) 2 (6.5) 1 (3.2) 1 (3.2) 3 (9.6)
UCTD – 4 (13.8) 10 (34.5) 9 (31.0) 1 (3.4) 3 (10.3) 2 (6.9) –
SSc – – 3 (50.0) 2 (33.3) – . – 1 (16.6)
PsA 7 (6.7) 10 (9.6) 24 (23.1) 20 (19.2) 1 (0.9) 18 (17.3) 8 (7.7) 16 (15.4)
PR 5 (21.7) – 5 (21.7) 3 (13.0) 4 (17.4) 2 (8.7) 2 (8.7) 2 (8.7)
FM 4 (12.5) 1 (3.1) 10 (31.2) 5 (15.6) 1 (3.1) 5 (15.6) 1 (3.1) 5 (15.6)
CP – – – 1 (11.1) – 4 (44.4) 2 (22.2) 2 (22.2)
Legend: RA: Rheumatoid Arthritis; OA: osteoarthritis; AS: ankylosing spondylitis; SLE: Systemic Lupus Erythematosus; SS: Sjögren Syn-
drome; UCTD: undifferentiated connective tissue diseases; SSc: Systemic Sclerosis; PsA: Psoriatic Arthritis; PR: Polymialgia  Rheumatica; 
FM: Fibromyalgia; CP: Crystal pathologies.
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Concerning the joints evaluated the most frequent 
requested were the hand joints (403 cases, 28.9%), fol-
lowed by wrists (325, 23.3%), and knees (193 cases, 
33.7%). Table II reports the frequency of the joints ex-
amined by US.
The relative frequencies of the assessed joints de-
pending of the underlying disease are detailed in table III.
In OA the most frequently examined joints were the 
hand and the knee. The most frequently scanned joints in 
polymialgia  rheumatica (PR) were the shoulders (5 cas-
es, 21.7%) and hands (5 cases, 21.7%). In fibromyalgia 
hand joints were mostly assessed whereas in microcrystal 
arthropathy (gout and chondrocalcinosis) was the knee. 
In 174 of cases (30.4%) the US exam was requested for 
other indications. 
At the full sample level, the US evaluation was re-
quested more frequently for monitoring (55.7%) com-
pared to diagnosis (44.3%). Table IV reports the results 
on this aspect in the different diseases. 
The physician requesting the US examination was 
a rheumatologist in the majority of cases (461 cases, 
80.6%), with a statistical significant difference compared 
to the general practitioner (21 cases, 3.7%; p<0.0001), 
the orthopedic surgeon (3 cases, 0.5%; p<0.0001) or oth-
er physicians (87 cases, 15.2%; p<0.0001).
Discussions
The present study represents an epidemiological anal-
ysis that has been conducted to better characterize the use 
of MS-US in a university rheumatology unit.
In a period of three months follow-up, more than 500 
patients with different rheumatic conditions were evaluated 
by using US: this first and simple data confirms the diffu-
sion of this technique in the clinical rheumatology practice. 
The results, indicating that RA was the most frequent 
indication for US assessment, underline the great inter-
est of rheumatologists for this condition: data from the 
literature indicate the growing interest on the US appli-
cation in patients affected by RA [9-13]. Thanks to its 
great sensitivity in detecting abnormalities since early 
phase of disease and in identifying subclinical synovitis, 
US assessment is recommended as a complementary tool 
to the clinical evaluation [14]. In our opinion the results 
concerning the use of US in the patients affected by CTD 
such as SLE are of particular interest, as they confirm that 
US is used in different rheumatic pathologies other than 
arthropathies. The hand and wrist were the most evalu-
ated joints, followed by knee; these results show that the 
identification of RA is the most frequent indication for 
US examination. As widely demonstrated, these joints 
are the more frequently involved in patients affected by 
RA, but also in other rheumatic conditions, such as CTD 
or psoriatic arthritis. As expected, considering the joint 
involvement of the disease, the shoulder were more fre-
quently evaluated in patients with PR. 
In our patients the US examination was requested 
especially to monitor the rheumatic diseases except in 
patients with PR. In this group of patients, the US was 
requested mostly for the disease diagnosis (66.6%); this 
result is not surprising when considering the difficulties 
of clinical examination in the evaluation of shoulder and 
hip, the most frequently involved joints in PR. 
Finally, another important aspect is that almost exclu-
sively rheumatologists required the US evaluation. This 
finding may be interpreted in the context of the increasing 
applications and use of US in the rheumatology clinical 
practice with a growing interest of rheumatology in the field. 
In conclusion, US is a feasible imaging tool that has 
registered increasing applications in the rheumatology 
clinical practice over the last years. The presence of an 
US unit that is integrated in a university rheumatology 
department improves the applications of US in different 
rheumatic diseases as well as in different contexts. These 
aspects further increase the use of MS-US in rheumatolo-
gy in the concept of US as a bedside procedure that should 
be routinely applied in the daily practice in rheumatology.
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